What is the treatment for schistosomiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Schistosomiasis

Praziquantel is the drug of choice for treating all forms of schistosomiasis, with dosing regimens based on the infecting Schistosoma species. 1, 2, 3

First-line Treatment

  • For Schistosoma mansoni, S. intercalatum, and S. guineensis infections: Praziquantel 40 mg/kg orally as a single dose 1
  • For Schistosoma japonicum and S. mekongi infections: Praziquantel 60 mg/kg orally in two divided doses 1
  • For Schistosoma haematobium: Praziquantel 40 mg/kg orally as a single dose 4, 1
  • Ensure sufficient dosage and duration to completely eradicate the organism from the body 4

Special Clinical Scenarios

Acute Schistosomiasis (Katayama Syndrome)

  • Occurs 2-8 weeks after exposure to contaminated water, primarily in travelers 5
  • Presents with eosinophilia (sometimes >5×10⁹/L), fever, dry cough, urticarial rash, and potentially pulmonary infiltrates 5
  • Treatment approach:
    • Praziquantel 40 mg/kg as a single dose, repeated at 6-8 weeks (eggs and immature schistosomules are relatively resistant to initial treatment) 5
    • Corticosteroids (prednisolone 20 mg/day for 5 days) to reduce symptom duration 5, 1
    • Consider administering steroids before anthelmintic therapy to prevent symptom exacerbation 1

Neuroschistosomiasis

  • Praziquantel 40 mg/kg twice daily for 5 days for CNS involvement 1
  • Combine with dexamethasone 4 mg four times daily, reducing after 7 days, for 2-6 weeks 1

Diagnostic Considerations

  • Diagnosis of schistosomiasis requires:
    • Concentrated stool microscopy for S. mansoni, S. japonicum, S. intercalatum, and S. mekongi 5, 6
    • Terminal urine microscopy for S. haematobium 5, 6
    • Serology (particularly useful in travelers with recent exposure) 5, 6
  • For acute schistosomiasis (Katayama syndrome), serology and stool/urine microscopy may be negative initially 5
  • Test for endemic coinfections (Salmonella, HBV, HCV, HIV), as targeted treatment may alter disease progression 5, 4

Monitoring and Follow-up

  • Serology may remain positive for years after successful treatment and cannot be used to assess treatment success 4, 1
  • Monitor patients with hepatic fibrosis from schistosomiasis for the development of kidney disease 5, 4
  • Evaluate patients with elevated serum creatinine and/or hematuria for bladder cancer and/or urinary obstruction, which are common complications of S. haematobium infection 5, 4

Common Pitfalls to Avoid

  • Failing to adjust dosage based on Schistosoma species can lead to treatment failure 1
  • Administering praziquantel during acute Katayama syndrome without steroids may worsen symptoms 1
  • Consider potential co-infection with strongyloidiasis before starting corticosteroids, which could precipitate hyperinfection syndrome 1
  • No immunosuppressive agents are indicated in schistosomal nephropathy beyond the corticosteroids used for acute management 5, 4

Additional Considerations

  • Praziquantel is safe and efficacious against adult worms of all Schistosoma species infecting humans 2, 3
  • Current concerns include the potential emergence of drug resistance and the fact that praziquantel does not prevent reinfection 2, 7
  • For patients in endemic areas, prevention strategies including snail control, improved water/sanitation, and education are essential components of disease management 2, 3

References

Guideline

Treatment of Bilharzia (Schistosomiasis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Schistosomiasis.

Nature reviews. Disease primers, 2018

Research

Human schistosomiasis: clinical perspective: review.

Journal of advanced research, 2013

Guideline

Treatment of Perirenal Adenopathy Associated with Schistosoma Hematobium

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

New diagnostic tools in schistosomiasis.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2015

Research

Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets.

Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.